Pharmaceutical process & drug discovery funding calls
Open calls relevant to pharmaceutical process research, chemical probes and drug-discovery chemistry. They include calls from NIH, the MRC and Horizon Europe health clusters. Eligibility differs a lot between these funders, so read the plain-language note on each call.
Small molecule high throughput screen using AstraZeneca facilities
Deadline: 28 Jan 2027 (105 days)
chemistrypharma processestablished / PI
Development of cell-free protein synthesis platforms for discovery and/or production of biologicals
Deadline: 17 Feb 2027 (125 days)
chemistrypharma processestablished / PI
Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Deadline: 17 Feb 2027 (125 days)
pharma processestablished / PI
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Deadline: 05 Mar 2027 (141 days)
chemistrypharma processestablished / PI
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
Deadline: 05 Nov 2027 (386 days)
chemistrypharma processestablished / PI
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Deadline: 20 Feb 2029 (859 days)
chemistrypharma processestablished / PI
Get new pharmaceutical process & drug discovery calls by email every week: Subscribe free